Search Results - "SHRIVER, Craig D"

Molecular heterogeneity in breast cancer: State of the science and implications for patient care by Ellsworth, Rachel E., Blackburn, Heather L., Shriver, Craig D., Soon-Shiong, Patrick, Ellsworth, Darrell L.

“…The identification of extensive genetic heterogeneity in human breast carcinomas poses a significant challenge for designing effective treatment regimens…”
Get full text

Incidence rates of digestive cancers among U.S. military servicemen: Comparison with the rates in the general U.S. population by Bytnar, Julie A, Shriver, Craig D, Zhu, Kangmin

“…Digestive cancers greatly contribute to the cancer burden in the United States. These cancers are more common among men and some are increasing among adults…”
Get full text

Functional role of vitronectin in breast cancer by Bera, Alakesh, Subramanian, Madhan, Karaian, John, Eklund, Michael, Radhakrishnan, Surya, Gana, Nahbuma, Rothwell, Stephen, Pollard, Harvey, Hu, Hai, Shriver, Craig D, Srivastava, Meera

“…Breast Cancer is the most common form of cancer in women worldwide, impacting nearly 2.1 million women each year. Identification of new biomarkers could be key…”
Get full text

Comparison of Breast Cancer Molecular Features and Survival by African and European Ancestry in The Cancer Genome Atlas by Huo, Dezheng, Hu, Hai, Rhie, Suhn K, Gamazon, Eric R, Cherniack, Andrew D, Liu, Jianfang, Yoshimatsu, Toshio F, Pitt, Jason J, Hoadley, Katherine A, Troester, Melissa, Ru, Yuanbin, Lichtenberg, Tara, Sturtz, Lori A, Shelley, Carl S, Benz, Christopher C, Mills, Gordon B, Laird, Peter W, Shriver, Craig D, Perou, Charles M, Olopade, Olufunmilayo I

“…African Americans have the highest breast cancer mortality rate. Although racial difference in the distribution of intrinsic subtypes of breast cancer is…”
Get more information

Selection of optimal quantile protein biomarkers based on cell-level immunohistochemistry data by Yi, Misung, Zhan, Tingting, Peck, Amy R, Hooke, Jeffrey A, Kovatich, Albert J, Shriver, Craig D, Hu, Hai, Sun, Yunguang, Rui, Hallgeir, Chervoneva, Inna

“…Protein biomarkers of cancer progression and response to therapy are increasingly important for improving personalized medicine. Advanced quantitative…”
Get full text

Effect of ASCO/CAP Guidelines for Determining ER Status on Molecular Subtype by Deyarmin, Brenda, Kane, Jennifer L., Valente, Allyson L., van Laar, Ryan, Gallagher, Christopher, Shriver, Craig D., Ellsworth, Rachel E.

“…Background Determination of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) status is standard for…”
Get full text

Cancer stage at diagnosis: Comparison of insurance status in SEER to the Department of Defense Cancer Registry by Flanary, James T., Lin, Jie, Shriver, Craig D., Zhu, Kangmin

“…Background Military individuals, retirees, and their families have free care or minimal out‐of‐pocket costs in the US military health system (MHS). In…”
Get full text

Assessing the quality of RNA isolated from human breast tissue after ambient room temperature exposure by Somiari, Stella B, Shuss, Susan, Liu, Jianfang, Mamula, Kimberly, O'Donnell, Amy, Deyarmin, Brenda, Kane, Jennifer, Greenawalt, Amber, Larson, Caroline, Rigby, Sean, Hu, Hai, Shriver, Craig D

“…High quality human tissue is essential for molecular research, but pre-analytical conditions encountered during tissue collection could degrade tissue RNA. We…”
Get full text

Impact of age at diagnosis on racial disparities in endometrial cancer patients by Tarney, Christopher M., Tian, Chunqiao, Wang, Guisong, Dubil, Elizabeth A., Bateman, Nicholas W., Chan, John K., Elshaikh, Mohamed A., Cote, Michele L., Schildkraut, Joellen M., Shriver, Craig D., Conrads, Thomas P., Hamilton, Chad A., Maxwell, G. Larry, Darcy, Kathleen M.

“…Although black patients with endometrial cancer (EC) have worse survival compared with white patients, the interaction between age/race has not been examined…”
Get full text

Proteogenomic characterization of difficult-to-treat breast cancer with tumor cells enriched through laser microdissection by Raj-Kumar, Praveen-Kumar, Lin, Xiaoying, Liu, Tao, Sturtz, Lori A, Gritsenko, Marina A, Petyuk, Vladislav A, Sagendorf, Tyler J, Deyarmin, Brenda, Liu, Jianfang, Praveen-Kumar, Anupama, Wang, Guisong, McDermott, Jason E, Shukla, Anil K, Moore, Ronald J, Monroe, Matthew E, Webb-Robertson, Bobbie-Jo M, Hooke, Jeffrey A, Fantacone-Campbell, Leigh, Mostoller, Brad, Kvecher, Leonid, Kane, Jennifer, Melley, Jennifer, Somiari, Stella, Soon-Shiong, Patrick, Smith, Richard D, Mural, Richard J, Rodland, Karin D, Shriver, Craig D, Kovatich, Albert J, Hu, Hai

“…Breast cancer (BC) is the most commonly diagnosed cancer and the leading cause of cancer death among women globally. Despite advances, there is considerable…”
Get full text

Eligibility, uptake and response to germline genetic testing in women with DCIS by Turza, Lauren, Lovejoy, Leann A, Turner, Clesson E, Shriver, Craig D, Ellsworth, Rachel E

“…Ductal carcinoma (DCIS) is a malignant, yet pre-invasive disease of the breast. While the majority of DCIS have low risk of recurrence, a subset of women with…”
Get full text

Role for chondroitin sulfate glycosaminoglycan in NEDD9-mediated breast cancer cell growth by Iida, Joji, Dorchak, Jesse, Clancy, Rebecca, Slavik, Juliana, Ellsworth, Rachel, Katagiri, Yasuhiro, Pugacheva, Elena N., van Kuppevelt, Toin H., Mural, Richard J., Cutler, Mary Lou, Shriver, Craig D.

“…There are lines of evidence demonstrating that NEDD9 (Cas-L, HEF-1) plays a key role in the development, progression, and metastasis of breast cancer cells. We…”
Get full text

The Impact of Preexisting Mental Health Disorders on the Diagnosis, Treatment, and Survival among Lung Cancer Patients in the U.S. Military Health System by Lin, Jie, McGlynn, Katherine A, Carter, Corey A, Nations, Joel A, Anderson, William F, Shriver, Craig D, Zhu, Kangmin

“…Higher cancer-related mortality has been observed among people with mental health disorders than in the general population. Both delay in diagnosis and…”
Get full text

Management of Incidental Findings in the Era of Next-generation Sequencing by Blackburn, Heather L, Schroeder, Bradley, Turner, Clesson, Shriver, Craig D, Ellsworth, Darrell L, Ellsworth, Rachel E

“…Next-generation sequencing (NGS) technologies allow for the generation of whole exome or whole genome sequencing data, which can be used to identify novel…”
Get full text

Chemotherapy Treatment Costs and Clinical Outcomes of Colon Cancer in the U.S. Military Health System’s Direct and Private Sector Care Settings by Eaglehouse, Yvonne L, Seabury, Seth A, Aljehani, Mayada, Koehlmoos, Tracey, Lee, Jerry S H, Shriver, Craig D, Zhu, Kangmin

“…ABSTRACT Introduction Identifying low-value cancer care may be an important step in containing costs associated with treatment. Low-value care occurs when the…”
Get full text

DNA aptamers against exon v10 of CD44 inhibit breast cancer cell migration by Iida, Joji, Clancy, Rebecca, Dorchak, Jesse, Somiari, Richard I, Somiari, Stella, Cutler, Mary Lou, Mural, Richard J, Shriver, Craig D

“…CD44 adhesion molecules are expressed in many breast cancer cells and have been demonstrated to play a key role in regulating malignant phenotypes such as…”
Get full text

Validation of tumor protein marker quantification by two independent automated immunofluorescence image analysis platforms by Peck, Amy R, Girondo, Melanie A, Liu, Chengbao, Kovatich, Albert J, Hooke, Jeffrey A, Shriver, Craig D, Hu, Hai, Mitchell, Edith P, Freydin, Boris, Hyslop, Terry, Chervoneva, Inna, Rui, Hallgeir

“…Protein marker levels in formalin-fixed, paraffin-embedded tissue sections traditionally have been assayed by chromogenic immunohistochemistry and evaluated…”
Get full text

Does Breast Tumor Heterogeneity Necessitate Further Immunohistochemical Staining on Surgical Specimens? by Greer, Lauren T., MD, Rosman, Martin, MD, Mylander, W. Charles, PhD, Hooke, Jeffrey, MD, Kovatich, Albert, MS, Sawyer, Kristen, MS, Buras, Robert R., MD, FACS, Shriver, Craig D., MD, FACS, Tafra, Lorraine, MD, FACS

“…Background Prognostic and predictive tumor markers in breast cancer are most commonly performed on core needle biopsies (CNB) of the primary tumor. Because…”
Get full text

Breast Cancer in the Personal Genomics Era by Ellsworth, Rachel E, Decewicz, David J, Shriver, Craig D, Ellsworth, Darrell L

“…Breast cancer is a heterogeneous disease with a complex etiology that develops from different cellular lineages, progresses along multiple molecular pathways,…”
Get full text

Single-cell sequencing and tumorigenesis: improved understanding of tumor evolution and metastasis by Ellsworth, Darrell L., Blackburn, Heather L., Shriver, Craig D., Rabizadeh, Shahrooz, Soon-Shiong, Patrick, Ellsworth, Rachel E.

“…Extensive genomic and transcriptomic heterogeneity in human cancer often negatively impacts treatment efficacy and survival, thus posing a significant ongoing…”
Get full text